Protara Therapeutics TARA
NASDAQ TARA
$3.94 -0.03 (-0.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Goodwill & Intangibles (2020 - 2022)

Protara Therapeutics (TARA) posted quarterly Goodwill & Intangibles of $29.5 million for Q3 2022, little changed year-over-year from $29.5 million in Q3 2021, and little changed quarter-over-quarter from $29.5 million in Q2 2022.

Analysis

Protara Therapeutics (TARA) Goodwill & Intangibles (2020 - 2022) Analysis & Trends

Protara Therapeutics (TARA) has reported Goodwill & Intangibles for 3 consecutive years, with $29.5 million the latest figure, recorded in Q3 2022.

  • In Q3 2022, Goodwill & Intangibles changed 0.0% year-over-year to $29.5 million; the TTM figure through Sep 2022 stood at $29.5 million (changed 0.0% YoY), while the FY2021 annual figure was $29.5 million, changed 0.0% from the prior year.
  • Goodwill & Intangibles was little changed at $29.5 million in Q3 2022 per TARA's latest filing, from $29.5 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $29.5 million in Q4 2020 and bottomed at $29.4 million in Q1 2020.
  • Historically, Goodwill & Intangibles has averaged $29.5 million across 3 years, with a median of $29.5 million in 2020.
  • On a YoY basis, Goodwill & Intangibles climbed as much as 0.51% in 2021 and fell as far as 0.0% in 2021.
  • Protara Therapeutics' Goodwill & Intangibles stood at $29.5 million in 2020, then changed by 0.0% to $29.5 million in 2021, then changed by 0.0% to $29.5 million in 2022.
  • Business Quant data shows TARA's Goodwill & Intangibles at $29.5 million in Q3 2022, $29.5 million in Q2 2022, and $29.5 million in Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Protara Therapeutics 241.28 Mn 241.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 29.52 Mn
Jun 30, 2022 29.52 Mn
Mar 31, 2022 29.52 Mn
Dec 31, 2021 29.52 Mn
Sep 30, 2021 29.52 Mn
Jun 30, 2021 29.52 Mn
Mar 31, 2021 29.52 Mn
Dec 31, 2020 29.52 Mn
Sep 30, 2020 29.37 Mn
Jun 30, 2020 29.37 Mn
Mar 31, 2020 29.37 Mn